The World Health Organization (WHO) has decided to carry out various support activities so that even low-income countries can obtain insulin, a diabetes drug, at a low cost.

The World Health Organization (WHO) issued a statement on Diabetes Day on November 14th, proposing a plan to increase access to insulin. WHO and the International Diabetes Federation have designated this day as 'Diabetes Day' to raise awareness of diabetes and promote prevention and treatment.

Diabetes is a disease in which blood glucose levels are high and excreted in the urine. If left untreated, it can lead to amputation of fingers and toes, loss of eyesight, etc. In severe cases, it can lead to death. In connection with this, it has been pointed out that although insulin, a diabetes treatment, has insufficient supply, it is difficult to obtain in low-income countries due to its high price.

In order to solve this problem, WHO has decided to focus on promoting the supply of insulin biosimilars (duplicable drugs of biopharmaceuticals). First, it plans to invest in insulin biosimilar infrastructure. It also promotes proposals to simplify the regulatory information that applies when a country approves biosimilars for marketing.

It also suggested improving the system so that diabetes-related medical equipment can be procured smoothly.